Want to join the conversation?
$WHR said in North America it performed in line with expectations in 1Q16, by growing revenue 5% excluding currency and expanding operating margins 70 BPs to 10.5%. Unit sellout in the quarter outpaced the industry, behind the strength of the company's recently launched products and the investments made to drive profitable growth.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)